Vaxcyte, Inc. (PCVX) Stock Overview
Explore Vaxcyte, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Vaxcyte, Inc. (PCVX)
Key Financials
Key Financials
Market Cap
7.9B
P/E Ratio
-7.93
EPS (TTM)
$-6.88
ROE
-0.33%
PCVX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Vaxcyte, Inc. (NASDAQ: PCVX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Vaxcyte, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PCVX on the NASDAQ shows an RSI of 48.35, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $50.13 for the NASDAQ listing.
Key metrics behind Vaxcyte, Inc.'s NASDAQ-traded stock include a P/E ratio of -7.93 and a market capitalization of 7.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PCVX on the NASDAQ.